These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MicroRNA-155 inhibition up-regulates LEPR to inhibit osteoclast activation and bone resorption via activation of AMPK in alendronate-treated osteoporotic mice. Mao Z, Zhu Y, Hao W, Chu C, Su H. IUBMB Life; 2019 Dec; 71(12):1916-1928. PubMed ID: 31317664 [Abstract] [Full Text] [Related]
3. Osteoblast-Targeting-Peptide Modified Nanoparticle for siRNA/microRNA Delivery. Sun Y, Ye X, Cai M, Liu X, Xiao J, Zhang C, Wang Y, Yang L, Liu J, Li S, Kang C, Zhang B, Zhang Q, Wang Z, Hong A, Wang X. ACS Nano; 2016 Jun 28; 10(6):5759-68. PubMed ID: 27176123 [Abstract] [Full Text] [Related]
4. A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclasts. Liu J, Dang L, Li D, Liang C, He X, Wu H, Qian A, Yang Z, Au DW, Chiang MW, Zhang BT, Han Q, Yue KK, Zhang H, Lv C, Pan X, Xu J, Bian Z, Shang P, Tan W, Liang Z, Guo B, Lu A, Zhang G. Biomaterials; 2015 Jun 28; 52():148-60. PubMed ID: 25818421 [Abstract] [Full Text] [Related]
5. Alendronate Functionalized Bone-Targeting Pomolic Acid Liposomes Restore Bone Homeostasis for Osteoporosis Treatment. Xia D, Qian Q, Wang S, Dong X, Liu Y. Int J Nanomedicine; 2024 Jun 28; 19():7983-7996. PubMed ID: 39135672 [Abstract] [Full Text] [Related]
6. Anti-osteopontin monoclonal antibody prevents ovariectomy-induced osteoporosis in mice by promotion of osteoclast apoptosis. Zhang B, Dai J, Wang H, Wei H, Zhao J, Guo Y, Fan K. Biochem Biophys Res Commun; 2014 Sep 26; 452(3):795-800. PubMed ID: 25201732 [Abstract] [Full Text] [Related]
7. YC-1 alleviates bone loss in ovariectomized rats by inhibiting bone resorption and inducing extrinsic apoptosis in osteoclasts. Wang JW, Yeh CB, Chou SJ, Lu KC, Chu TH, Chen WY, Chien JL, Yen MH, Chen TH, Shyu JF. J Bone Miner Metab; 2018 Sep 26; 36(5):508-518. PubMed ID: 28983668 [Abstract] [Full Text] [Related]
8. Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients. Jobke B, Milovanovic P, Amling M, Busse B. Bone; 2014 Feb 26; 59():37-43. PubMed ID: 24211427 [Abstract] [Full Text] [Related]
10. The role of microRNAs in osteoclasts and osteoporosis. Tang P, Xiong Q, Ge W, Zhang L. RNA Biol; 2014 Feb 26; 11(11):1355-63. PubMed ID: 25692234 [Abstract] [Full Text] [Related]
12. Low‑molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats. Jin X, Zhu L, Li X, Jia J, Zhang Y, Sun X, Ma J, Liu Z, Ma X. Mol Med Rep; 2017 Feb 26; 15(2):890-898. PubMed ID: 28000877 [Abstract] [Full Text] [Related]
15. MicroRNAs and their roles in osteoclast differentiation. Xia Z, Chen C, Chen P, Xie H, Luo X. Front Med; 2011 Dec 26; 5(4):414-9. PubMed ID: 22198753 [Abstract] [Full Text] [Related]
16. [Current topics in drug therapy aiming at bone resorption]. Yasui T, Tanaka S. Clin Calcium; 2006 Sep 26; 16(9):1475-79. PubMed ID: 16951471 [Abstract] [Full Text] [Related]
17. [Frontiers in vitamin D; basic research and clinical application. Inhibitory effects of eldecalcitol, an active vitamin D derivative, on bone resorption in vivo]. Harada S, Mizoguchi T, Takahashi N. Clin Calcium; 2011 Nov 26; 21(11):91-8. PubMed ID: 22040825 [Abstract] [Full Text] [Related]
18. Perspectives on osteoporosis therapies. Cairoli E, Zhukouskaya VV, Eller-Vainicher C, Chiodini I. J Endocrinol Invest; 2015 Mar 26; 38(3):303-11. PubMed ID: 25577263 [Abstract] [Full Text] [Related]
19. Role of Biomolecules in Osteoclasts and Their Therapeutic Potential for Osteoporosis. Zhao X, Patil S, Xu F, Lin X, Qian A. Biomolecules; 2021 May 17; 11(5):. PubMed ID: 34067783 [Abstract] [Full Text] [Related]